A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference.

Address: University of Birmingham, Birmingham, UK Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany Atrial Fibrillation Network (AFNET), Germany [email protected].; Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany Atrial Fibrillation Network (AFNET), Germany.; Leiden University Medical Center, Leiden, The Netherlands.; Atrial Fibrillation Network (AFNET), Germany.; Department of Cardiology, Institution of Medical Sciences, Uppsala University, Uppsala, Sweden.; DIMES Department, University of Bologna, Bologna, Italy.; Odense University Hospital, Odense, Denmark.; Meda Pharma SAS, Paris, France.; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.; The Johns Hopkins Hospital, Baltimore, MD, USA.; University of Birmingham, Birmingham, UK.; University of Amsterdam, Amsterdam, The Netherlands.; University Hospital Maastricht, Maastricht, The Netherlands.; University Duisburg-Essen, Essen, Germany.; Harvard University, Boston, USA.; University of Birmingham, Birmingham, UK Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany.; CRI-The Clinical Research Institute, Munich, Germany.; University of Sydney, Sydney, Australia.; Atrial Fibrillation Network (AFNET), Germany Ludwig-Maximilians-University, Munich, Germany.; Atrial Fibrillation Network (AFNET), Germany St Vincenz Krankenhaus, Paderborn, Germany.; Hospital Clinic, Universitat de Barcelona, Barcelona, Catalonia, Spain.; Bristol-Myers Squibb GmbH & Co. KGaA, Munich, Germany.; University Hospital, Zurich, Switzerland.; Institute of Cardiometabolism and Nutrition, INSERM UMR S 1166, Paris, France.; Atrial Fibrillation Network (AFNET), Germany Charité-Universitätsmedizin Berlin, Berlin, Germany.; Hasselt University and Heart Center, Hasselt, Belgium.; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.; Hopital Pitié-Salpêtrière AP HP, Paris, France.; University Hospital Leipzig, Leipzig, Germany.; Cardiome Pharma Corp., Vancouver, Canada.; Ludwig-Maximilians-University, Munich, Germany DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.; University of Lausanne, Lausanne, Switzerland.; Bayer HealthCare AG, Berlin, Germany.; Atrial Fibrillation Network (AFNET), Germany Isar Heart Center, Isarclinic Munich, Munich, Germany.; Medtronic International Trading Sàrl, Tolochenaz, Switzerland.; Daiichi Sankyo Europe GmbH, Munich, Germany.; Aarhus University Hospital, Aarhus, Denmark.; Atrial Fibrillation Network (AFNET), Germany Städtisches Klinikum Brandenburg, Brandenburg, Germany.; Department of Cardiology, Institution of Medical Sciences, Uppsala University, Uppsala, Sweden Uppsala Clinical Research Center, Uppsala, Sweden.; Department of Cardiology, Memorial Ankara Hospital, Ankara, Turkey.; Duke University Medical Center, Durham, NC, USA.; Boston Scientific, St Paul, MN, USA.; School of Medicine, University of Belgrade, Clinical Centre of Serbia, Belgrade, Serbia.; Atrial Fibrillation Network (AFNET), Germany TU Dresden, Dresden, Germany.; Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany.; Atrial Fibrillation Network (AFNET), Germany Universitätsmedizin Mainz, Mainz, Germany.; St George's Hospital Medical School, London, UK.; University Heart Center Hamburg, Germany.; Atrial Fibrillation Network (AFNET), Germany University Hospital Maastricht, Maastricht, The Netherlands.; Ludwig-Maximilians-University, Munich, Germany.; Atrial Fibrillation Network (AFNET), Germany Zentrum für Kardiologie am Klinikum Starnberg, Starnberg, Germany.; Genetic Epidemiology, Institute of Human Genetics, University of Muenster, Muenster, Germany CARIM Research School for Cardiovascular Diseases, University of Maastricht, Maastricht, The Netherlands.; Ettore Sansavini Health Science Foundation, Cotignola, Italy.; Ospedale dell'Angelo, Mestre-Venice, Italy.; University of Hong Kong, Hong Kong, China.; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Heraklion University Hospital, Heraklion, Crete, Greece.; VTT Technical Research Centre of Finland, Espoo, Finland.; Stroke Research Group, Department of Brain Repair and Rehabilitation, UCL Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK.; Roche Diagnostics International Ltd., Rotkreuz, Switzerland.